Medicare Enrolled

Dr. Abdul Orra, DO

Family Medicine · Lakewood, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
13535 DETROIT AVE #4, Lakewood, OH 44107
2162262626
In practice since 2006 (19 years)
NPI: 1053474320 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Orra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Orra? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Orra

Dr. Abdul Orra is a family medicine specialist in Lakewood, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Orra performed 539 Medicare services across 256 unique beneficiaries.

Between the years covered by Open Payments, Dr. Orra received a total of $20,593 from 67 pharmaceutical and/or device companies across 1482 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Orra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 45% volume in OH $20,593 industry payments

Medicare Practice Summary

Medicare Utilization ↗
539
Medicare services
Top 45% in OH for family medicine
256
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~28 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
246 $81 $155
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
164 $57 $125
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
58 $8 $15
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
43 $109 $185
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
28 $2 $40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$20,593
Total received (2018-2024)
Avg $2,942/year across 7 years
Top 1% in OH for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
1,482
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,593 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,288
2023
$2,983
2022
$2,963
2021
$3,379
2020
$2,885
2019
$2,625
2018
$2,470

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$643
ABBVIE INC.
$273
Lilly USA, LLC
$208
Novo Nordisk Inc
$204
PFIZER INC.
$199
Janssen Pharmaceuticals, Inc
$164
Antares Pharma, Inc.
$161
GlaxoSmithKline, LLC.
$145
Astellas Pharma US Inc
$103
Bayer Healthcare Pharmaceuticals Inc.
$103
SCILEX PHARMACEUTICALS INC.
$102
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$93
Amgen Inc.
$90
Exact Sciences Corporation
$81
E.R. Squibb & Sons, L.L.C.
$67
Mylan Specialty L.P.
$66
Merck Sharp & Dohme LLC
$62
Averitas Pharma Inc.
$62
Dexcom, Inc.
$62
Phathom Pharmaceuticals, Inc.
$61
Boehringer Ingelheim Pharmaceuticals, Inc.
$58
AIMMUNE THERAPEUTICS, INC.
$55
Corcept Therapeutics
$42
SHIELD THERAPEUTICS INC
$38
Novartis Pharmaceuticals Corporation
$35
Abbott Laboratories
$34
IRONWOOD PHARMACEUTICALS, INC
$27
Phadia US Inc.
$20
Xeris Pharmaceuticals, Inc.
$18
EVOKE PHARMA, INC.
$14
Top 3 companies account for 34.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,346
AstraZeneca Pharmaceuticals LP
$1,910
PFIZER INC.
$1,386
Lilly USA, LLC
$1,369
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,189
GlaxoSmithKline, LLC.
$1,044
Janssen Pharmaceuticals, Inc
$1,004
ABBVIE INC.
$906
Amgen Inc.
$880
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$647
AbbVie Inc.
$524
Amarin Pharma Inc.
$472
Novartis Pharmaceuticals Corporation
$441
Teva Pharmaceuticals USA, Inc.
$400
Nestle HealthCare Nutrition Inc.
$370
Biohaven Pharmaceutical Holding Company Ltd.
$367
Merck Sharp & Dohme Corporation
$358
Merck Sharp & Dohme LLC
$349
Allergan Inc.
$349
Bayer Healthcare Pharmaceuticals Inc.
$300
SANOFI-AVENTIS U.S. LLC
$292
Esperion Therapeutics, Inc.
$264
Allergan, Inc.
$257
Astellas Pharma US Inc
$244
Bayer HealthCare Pharmaceuticals Inc.
$215
Sunovion Pharmaceuticals Inc.
$213
E.R. Squibb & Sons, L.L.C.
$209
Ironwood Pharmaceuticals, Inc
$168
Antares Pharma, Inc.
$161
Takeda Pharmaceuticals U.S.A., Inc.
$138
SCILEX PHARMACEUTICALS INC.
$135
Abbott Laboratories
$120
Supernus Pharmaceuticals, Inc.
$95
Scilex Pharmaceuticals Inc.
$92
IRONWOOD PHARMACEUTICALS, INC
$91
Exact Sciences Corporation
$81
AIMMUNE THERAPEUTICS, INC.
$72
Xeris Pharmaceuticals, Inc.
$72
Horizon Therapeutics plc
$70
Mylan Specialty L.P.
$66
Averitas Pharma Inc.
$62
Dexcom, Inc.
$62
Phathom Pharmaceuticals, Inc.
$61
NESTLE HEALTHCARE NUTRITION INC.
$56
Kowa Pharmaceuticals America, Inc.
$49
Otsuka America Pharmaceutical, Inc.
$49
Ironshore Pharmaceuticals Inc.
$48
Corcept Therapeutics
$42
AbbVie, Inc.
$42
RedHill Biopharma Inc.
$40
SHIELD THERAPEUTICS INC
$38
Avanir Pharmaceuticals, Inc.
$37
Ultragenyx Pharmaceutical Inc.
$34
Lundbeck LLC
$31
Mannkind Corporation
$30
EVOKE PHARMA, INC.
$29
Purdue Pharma L.P.
$24
Genentech USA, Inc.
$23
Biohaven Pharmaceuticals, Inc.
$22
VIVUS LLC
$22
GRT US Holding, Inc.
$22
Phadia US Inc.
$20
Almatica Pharma LLC
$19
Shield Therapeutics Inc
$19
Circassia Pharmaceuticals Inc
$19
Regeneron Healthcare Solutions, Inc.
$15
Ardelyx, Inc.
$13
Top 3 companies account for 27.4% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AFREZZA · AIMOVIG · AIRSUPRA · AJOVY · ANORO ELLIPTA · AREXVY · ASMANEX · Aimovig · AirDuo Digihaler · BAQSIMI · BASAGLAR · BELSOMRA · BREO · BREO ELLIPTA · BREZTRI · BYDUREON · BYSTOLIC · CAMZYOS · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · Cologuard Collection Kit · Creon · Cryvista · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GIMOTI · GRALISE · GVOKE HYPOPEN · GVOKE PFS · IBSRELA · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · Jornay PM 20mg capsules (Bottle of 100) · KRYSTEXXA · Kerendia · Korlym · LATUDA · LEQVIO · LINZESS · LONHALA MAGNAIR · LYRICA · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Movantik · Myrbetriq · NEXLETOL · NEXLIZET · NORTHERA · NUEDEXTA · NURTEC ODT · NovoSeven · OFEV · Otezla · Ozempic · PANCREAZE · PAXLOVID · PRADAXA · PRALUENT · Prolia · QULIPTA · QUTENZA · Qutenza · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · SYNJARDY · Saxenda · TLANDO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULANCE · TRULICITY · TUDORZA PRESSAIR · Talicia · Tresiba · Trintellix · UBRELVY · VERQUVO · VESICARE · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xofluza · YUPELRI · ZENPEP · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in OH.

Looking for a family medicine specialist in Lakewood?
Compare family medicine physicians in the Lakewood area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
691
Per 100K population
55.3
County median income
$62,823
Nearest hospital
FAIRVIEW HOSPITAL
2.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Orra is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 1% of OH peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Orra experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Orra performed 246 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Orra receive payments from pharmaceutical companies?
Yes. Dr. Orra received a total of $20,593 from 67 companies across 1,482 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Orra's costs compare to other family medicine physicians in Lakewood?
Dr. Orra's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Orra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →